Asarfi Hospital Ltd vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Asarfi Hospital Ltd is ₹ 229.9 as of 17 Jun 10:31 . The P/E Ratio of Asarfi Hospital Ltd changed from 31 on March 2024 to 20 on March 2026 . This represents a CAGR of -13.59% over 3 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Asarfi Hospital Ltd changed from ₹ 128.55 crore on March 2024 to ₹ 333.63 crore on March 2026 . This represents a CAGR of 37.42% over 3 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Asarfi Hospital Ltd for the Jun '26 is ₹ 48.1 crore as compare to the Mar '26 revenue of ₹ 45.89 crore. This represent the growth of 4.82% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of Asarfi Hospital Ltd for the Jun '26 is ₹ 10.02 crore as compare to the Mar '26 ebitda of ₹ 8.36 crore. This represent the growth of 19.86% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of Asarfi Hospital Ltd changed from ₹ 1.45 crore to ₹ 4.27 crore over 9 quarters. This represents a CAGR of 61.61% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Asarfi Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Asarfi Hospital Ltd

Asarfi Hospital Limited was originally incorporated as Private Limited Company in the name of 'Asarfi Hospital Private Limited' on October 4, 2005 issued by Registrar of Companies, Bihar & Jharkhand.
Subsequently, status of the Company was converted into Public Limited and name of the Company was changed to 'Asarfi Hospital Limited' vide a fresh Certificate of Incorporation dated February 08, 2012 issued by Registrar of Companies, Jharkhand. Asarfi Ltd is a 250 bedded Multi Speciality Hospital, which is serving people for more than one and half decade by providing healthcare services in Dhanbad, Jharkhand.
Accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL Accredited).
The Company is an integrated healthcare service provider, committed to deliver quality healthcare services to their patients in modern facilities that includes prevention, best treatment and proper rehabilitation.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of Asarfi Hospital Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, Asarfi Hospital Ltd or Transgene Biotek Ltd?

Market cap of Asarfi Hospital Ltd is 313 Cr while Market cap of Transgene Biotek Ltd is 17 Cr

What are the key factors driving the stock performance of Asarfi Hospital Ltd and Transgene Biotek Ltd?

The stock performance of Asarfi Hospital Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Asarfi Hospital Ltd and Transgene Biotek Ltd?

As of October 31, 2026, the Asarfi Hospital Ltd stock price is INR ₹159.4. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.33.

How do dividend payouts of Asarfi Hospital Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of Asarfi Hospital Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.